Clinical Trials Directory

Trials / Terminated

TerminatedNCT00944125

Dual Site Left Ventricular (LV) Pacing

Dual Site LV Pacing Study: Prospective Randomized Blinded Crossover Study of Patients Meeting Current CRT-D Indication to be Implanted With Dual LV Pacing Leads and Paced Chronically for at Least 6 Months Post-implant.

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Wake Forest University Health Sciences · Academic / Other
Sex
All
Age
40 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare Dual LV (left ventricular) pacing to standard single LV pacing (BiV pacing) to see if Dual LV pacing: 1. Improves the way the heart's left ventricle functions 2. Decreases the number of hospital and clinic visits for heart failure related symptoms 3. Slows the rate patients experience certain heart failure symptoms 4. Reduces uncoordinated heart contractions

Conditions

Interventions

TypeNameDescription
DEVICEDual Site LV PacingDual Site LV Pacing vs. BiV Pacing for a total of six months which includes two three crossover periods.
DEVICEBiV PacingDual Site LV Pacing vs. BiV Pacing for a total of six months which includes two three crossover periods.

Timeline

Start date
2009-06-01
Primary completion
2013-07-01
Completion
2013-07-01
First posted
2009-07-23
Last updated
2024-10-21
Results posted
2016-03-21

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00944125. Inclusion in this directory is not an endorsement.